STEMMER IMAGING AG publishes quarterly figures: Significant growth in revenue and earnings; earnings forecast raised

Stemmer Imaging
  • Revenue increase by 29.7 per cent to EUR 30.5 million in the first three months of the planned short financial year 2019 (previous year: EUR 23.5 million)
  • Adjusted operating result (EBITDA) of EUR 4.0 million and an EBITDA margin of 13.1 per cent are significantly above the level of the previous year (EUR 2.3 million / EBITDA margin 9.7 per cent)
  • Acquisition of machine learning software algorithms for the further development of the Common Vision Blox software library in the Deep Learning segment
  • Announcement of one-time expenses of EUR 1.5 million for Q2 2019 by bringing forward costs from 2020 previously reported as adjusted
  • Forecast for planned short financial year 2019: revenue in the range of EUR 59.0 to 65.0 million and EBITDA forecast raised from EUR 5.5 – 7.1 million to EUR 6.0 – 7.5 million


No Comments

Leave a Reply

Your e-mail address will not be published. Required fields are marked *

Stemmer Imaging
STEMMER IMAGING appoints Director of Product Management

STEMMER IMAGING AG welcomes Johannes Hiltner as Director of Product Management. In his new role he leads the Product Management Team and is responsible for strategic planning and management of the product portfolio over the entire life cycle, with responsibility for product selection and supplier management. STEMMER IMAGING News

Stemmer Imaging
Large format CMOS cameras supersede CCD versions

Three new Allied Vision Prosilica GT Large Format cameras, with high-resolution 2 nd generation Sony IMX CMOS sensors, offer outstanding imaging performance. IEEE 1588 PTP and Trigger over Ethernet bring precise triggering using a single cable, reducing system costs and complexity. STEMMER IMAGING News

Stemmer Imaging
Aggregation in the pharmaceutical industry: product traceability via track & trace

Pharmaceutical companies achieve significant cost savings by using traceability and aggregation solutions. Moreover, they enable compliance with regulations for proof of origin and traceability of prescription drugs. A large part of these benefits result from improvements in process and supply chain efficiency. The Smart Manual Aggregation Table (SMAT) system from …